NTLA Competitors & Alternatives
Compare Intellia Therapeutics Inc with similar stocks in the same industry
Biotechnology
NTLA
Main Stock$10.68
Tradestie Score
50
Market Cap
$2.01B
Revenue Growth
-0.1%
Analyst Upside
+145.0%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.43
|
$1.63B | - | 50 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.50
|
$1.57B | - | 51 | Compare |
|
VCEL
Vericel Corporation
|
$45.96
|
$1.56B | 108.2 | 52 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$106.92
|
$1.55B | - | 56 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$35.24
|
$1.55B | 14.5 | 59 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$32.62
|
$1.55B | - | 59 | Compare |
|
NVAX
Novavax Inc
|
$7.32
|
$1.54B | - | 56 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$14.88
|
$1.50B | 6.9 | 56 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$48.04
|
$1.50B | - | 49 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$20.31
|
$1.49B | - | 60 | Compare |
More NTLA Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2835)
232 stocks in this industry